The role of radiosurgery in the treatment of grade 2 meningioma remains unclear. This study aimed to evaluate the long-term ...

Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research ...

Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.

During a live event, Naresh Bumma, MD, discussed talquetamab’s efficacy in relapsed/refractory multiple myeloma, including ...

Upper urinary tract urothelial carcinoma (UTUC) is categorised into low-risk (LR) and high-risk (HR) groups based on patient ...

(UroToday.com) Dr. Federico Zorzi presented his research on the potential of arteriogenic insufficiency assessed by penile doppler ultrasound as a predictor for major cardiovascular (CV) events in ...

The following is a summary of "Sex differences in outcomes in patients with acute myocardial infarction," published in the ...

Oncologic Outcomes in Patients Undergoing Radical Cystectomy for non–muscle-invasive bladder cancer (NMIBC) Following BCG Therapy Failure. Dr. Oberneder highlighted that the U.S. FDA has approved ...

A large cohort study from China and the U.S. shows that Circadian Syndrome (CircS)—a cluster of metabolic and behavioral ...

Overall survival was analyzed using the Kaplan-Meier method, showing survival rates comparable ... “Local therapies have a long history of a steep learning curve before optimal outcomes can be ...

The role of radiosurgery in the treatment of grade 2 meningioma remains unclear. This study aimed to evaluate the long-term ...